Sonnet BioTherapeutics Holdings, Inc. (SONN)
USD 1.61
(-6.4%)
USD 1.61
(-6.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -21.34 Million | -27.68 Million | -22.55 Million | -15.61 Million | -2.22 Million | -1.1 Million |
| Net Income | -18.83 Million | -29.72 Million | -24.98 Million | -24.26 Million | -4.87 Million | -6.86 Million |
| Depreciation & Amortization | 75.75 Thousand | 93.25 Thousand | 95.16 Thousand | 58.31 Thousand | 2.16 Million | 1.81 Million |
| Deferred income taxes | 2.63 Million | - | -125.5 Thousand | - | -702.59 Thousand | -779.35 Thousand |
| Stock-based compensation | 248.62 Thousand | 876.36 Thousand | 1.37 Million | 370.05 Thousand | 430 Thousand | - |
| Change in working capital | -3.11 Million | 93.46 Thousand | 1.08 Million | 1.39 Million | 2.12 Million | 2.62 Million |
| Other non-cash items | -2.34 Million | 971.47 Thousand | 623.00 | 6.82 Million | 516.23 Thousand | 3.02 Million |
| Investing Cash Flow | -443.25 Thousand | -896.47 Thousand | -3623.00 | -76.18 Thousand | -2.44 Million | -1.25 Million |
| Investments in PPE | -443.25 Thousand | -896.47 Thousand | -3623.00 | -76.18 Thousand | -2.39 Million | -1.69 Million |
| Acquisitions | - | - | - | - | 1.43 Million | 770 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -443.25 Thousand | -810.22 Thousand | - | - | -1.48 Million | -322.28 Thousand |
| Financing Cash Flow | 21 Million | 4.01 Million | 42.82 Million | 23 Million | 2.25 Million | 1.31 Million |
| Debt repayment | -748.00 | - | -20.43 Thousand | -110.73 Thousand | -864.55 Thousand | -270.57 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 21 Million | 1.84 Million | 42.84 Million | 19.07 Million | 2.84 Million | 1.68 Million |
| Other Financing Activities | 849.00 | 2.17 Million | 2.00 | 4.04 Million | 2.25 Million | -101.16 Thousand |
| Accounts receivables | -69.26 Thousand | - | - | - | 91.79 Thousand | 114 Thousand |
| Accounts payables | -2.63 Million | 971.04 Thousand | 1.72 Million | 168.8 Thousand | 1.38 Million | 2.51 Million |
| Inventory | 69.26 Thousand | - | - | - | 8885.00 | 72.8 Thousand |
| Other working capital | -484.3 Thousand | -877.58 Thousand | -637.73 Thousand | 1.22 Million | 639.02 Thousand | -74.29 Thousand |
| Cash at beginning of period | 3.05 Million | 27.62 Million | 7.34 Million | 35.65 Thousand | 5419.00 | 438.49 Thousand |
| Cash at end of period | 2.27 Million | 3.05 Million | 27.62 Million | 7.34 Million | 35.65 Thousand | 524.11 Thousand |
| Capital Expenditure | -443.25 Thousand | -896.47 Thousand | -3623.00 | -76.18 Thousand | -2.39 Million | -1.69 Million |
| Effect of forex changes on cash | - | - | - | - | -10.9 Thousand | -10.9 Thousand |
| Net cash flow / Change in cash | -778.62 Thousand | -24.56 Million | 20.27 Million | 7.31 Million | 30.23 Thousand | 85.61 Thousand |
| Free Cash Flow | -21.78 Million | -28.58 Million | -22.55 Million | -15.69 Million | -4.61 Million | -2.8 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.5 Million | 365.42 Thousand | -1.16 Million | -3.67 Million | -18.83 Million | -3.94 Million |
| Depreciation & Amortization | 21.03 Thousand | 20.49 Thousand | 19.97 Thousand | 19.46 Thousand | 75.75 Thousand | 18.97 Thousand |
| Deferred income taxes | - | - | 36.77 Thousand | -368.62 Thousand | 2.63 Million | 368.62 Thousand |
| Stock-based compensation | 60.39 Thousand | 60.39 Thousand | 50 Thousand | 50 Thousand | 248.62 Thousand | 50 Thousand |
| Change in working capital | -17.64 Thousand | 277.47 Thousand | -2 Million | -951.84 Thousand | -3.11 Million | -2.46 Million |
| Other non-cash items | 702.63 Thousand | 188.18 Thousand | -24.77 Thousand | 368.62 Thousand | -2.34 Million | -198.62 Thousand |
| Investing Cash Flow | -12 Thousand | - | - | -170 Thousand | -443.25 Thousand | -12 Thousand |
| Investments in PPE | -12 Thousand | - | - | -170 Thousand | -443.25 Thousand | -12 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -12 Thousand | - | - | -170 Thousand | -443.25 Thousand | -12 Thousand |
| Financing Cash Flow | 2.84 Million | 41 Thousand | 3.83 Million | -17.69 Thousand | 21 Million | 1.81 Million |
| Debt repayment | - | - | - | - | -748.00 | -748.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -17.69 Thousand | - | - |
| Common Stock Issuance | 2.99 Million | 56 Thousand | 3.83 Million | -17.69 Thousand | 21 Million | 1.81 Million |
| Other Financing Activities | -142.5 Thousand | -15 Thousand | 3.83 Million | - | 849.00 | 849.00 |
| Accounts receivables | -141.64 Thousand | -183.85 Thousand | 592.46 Thousand | -37.4 Thousand | -69.26 Thousand | -302.15 Thousand |
| Accounts payables | -86.35 Thousand | 97.05 Thousand | -465.73 Thousand | -753.99 Thousand | -2.63 Million | -1.49 Million |
| Inventory | - | - | - | 37.4 Thousand | 69.26 Thousand | 302.15 Thousand |
| Other working capital | 210.36 Thousand | 364.27 Thousand | -2.13 Million | -197.85 Thousand | -484.3 Thousand | -974.02 Thousand |
| Cash at beginning of period | 3.78 Million | 3.02 Million | 2.27 Million | 7.02 Million | 3.05 Million | 11.39 Million |
| Cash at end of period | 3.55 Million | 3.78 Million | 3.02 Million | 2.27 Million | 2.27 Million | 7.02 Million |
| Capital Expenditure | -12 Thousand | - | - | -170 Thousand | -443.25 Thousand | -12 Thousand |
| Effect of forex changes on cash | - | - | - | -4.56 Million | - | 4.56 Million |
| Net cash flow / Change in cash | -231.85 Thousand | 764.79 Thousand | 747.13 Thousand | -4.74 Million | -778.62 Thousand | -4.36 Million |
| Free Cash Flow | -3.08 Million | 723.79 Thousand | -3.09 Million | -4.72 Million | -21.78 Million | -6.18 Million |
600523
603680
ITMG
0LFS
6733
GKOS